Novartis names Mukul Mehta as CFO Ruchika Sharma17 July 2025 12:46 PM ISTBasel: Novartis has announced the appointment of Mukul Mehta as the Chief Financial Officer (CFO) and a member of the Executive Committee of...
Novartis loses legal battle to block US Entresto generic until 2026 Ruchika Sharma12 July 2025 12:23 PM ISTWashington: In a significant legal setback for Novartis, a Delaware federal judge has said that Swiss pharmaceutical giant cannot stop...
First Malaria Drug approved for Newborns and young infants: Study Dr. Kamal Kant Kohli11 July 2025 8:45 AM ISTNovartis has received approval for Coartem Baby, the world's first malaria treatment specifically for newborns and young infants. Approved by Swiss...
Breakthrough for babies: Novartis Coartem Baby approved as first Malaria drug for Infants Ruchika Sharma9 July 2025 1:30 PM ISTBasel: Novartis has received approval from Swissmedic for Coartem (artemether-lumefantrine) Baby, a first malaria medicine for newborns...
Novartis concludes acquisition of Regulus Therapeutics Ruchika Sharma26 Jun 2025 12:02 PM ISTBasel: Novartis has announced that it has successfully completed its acquisition of Regulus Therapeutics Inc. With the completion of the...
CDSCO Panel Asks Novartis to Submit Revised Protocol, Dose Changes for Ianalumab Phase III Trial Dr. Divya Colin1 Jun 2025 4:00 PM ISTNew Delhi: Reviewing the Phase III clinical of the Ianalumab (VAY736) presented by Novartis, the Subject Expert Committee (SEC) functional under the...
Novartis arm commences tender offer to buy Regulus Therapeutics Ruchika Sharma28 May 2025 11:00 AM ISTBasel: Novartis has announced that Redwood Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Novartis, has...
CDSCO Panel Recommends Protocol Amendment for Novartis' Ianalumab Trial Farhat Nasim21 May 2025 8:03 PM ISTNew Delhi: The Subject Expert Committee (SEC) on Haematology, functional under the Central Drugs Standard Control Organisation (CDSCO) has recommended...
CDSCO Panel Approves Novartis' Protocol Amendment proposal for Iptacopan Clinical study in Kidney Disorders Dr. Divya Colin10 May 2025 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the proposal...
Novartis executive Ramon Zapata-Gomez to join BioNTech as CFO Ruchika Sharma6 May 2025 3:30 PM ISTGermany: BioNTech SE has announced that the Supervisory Board has appointed Ramon Zapata-Gomez to the Management Board as Chief Financial...
Novartis to acquire kidney disease drug maker Regulus Therapeutics for up to 1.7 billion Ruchika Sharma1 May 2025 12:30 PM ISTTransaction includes USD 0.8 billion upfront with a potential additional USD 0.9 billion payment upon the achievement of a future regulatory...
Novartis plans to invest USD 23 billion over next 5 years in US based infrastructure Ruchika Sharma13 April 2025 12:30 PM ISTEast Hanover: Novartis, a global medicines company, has announced a planned USD 23 billion investment over 5 years in US-based infrastructure,...
